| Report | Options implied | Actual move | Market was |
|---|---|---|---|
| May 5, 2026 | ±2.7% | +2.2% | over-priced |
| February 3, 2026 | ±2.3% | +2.3% | under-priced |
| August 6, 2025 | ±2.2% | -4.7% | under-priced |
| May 7, 2025 | ±2.4% | +2.4% | over-priced |
| February 5, 2025 | ±2.1% | -2.3% | under-priced |
| August 7, 2024 | ±3.7% | -7.7% | under-priced |
| May 8, 2024 | ±1.9% | +4.9% | under-priced |
| February 7, 2024 | ±2.2% | +10.4% | under-priced |
| Quarter | EPS (dil.) | Revenue | Net income |
|---|---|---|---|
| Q2 FY2026 | — | $4.6B | $618M |
| Q1 FY2026 | $1.07 | $4.3B | $606M |
| Q4 FY2025 | $1.12 | $4.9B | $637M |
| Q3 FY2025 | $1.04 | $4.6B | $586M |
Emerson Electric Co. (EMR) reports in 74 days, with the next report estimated for August 26, 2026. Across the last 8 reports, options priced an average ±2.4% earnings move while the stock actually moved 4.6% on average — the market has tended to under-price EMR's earnings risk. Fundamentals into the print: EPS up 0.0% year-over-year, revenue up 2.9%. QuantLogix's live 5-factor engine currently reads EMR as a buy at 64/100.
Implied move is derived from at-the-money option pricing; actual moves are close-to-close on report days. Next-report dates are estimates until confirmed by the company. Educational market analysis, not investment advice. Browse all signal scorecards →